Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2015-07-10 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
董事会2015年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions passed at the 2015 first extraordinary shareholders' meeting of 普莱柯生物工程股份有限公司. It includes details about the meeting date, attendance, voting results on specific proposals, and legal verification by a law firm. The document does not contain financial statements or detailed financial analysis but reports on the voting outcomes and meeting procedures. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1628 characters), and it is not a report publication announcement or a regulatory filing. Therefore, the correct classification is DVA with high confidence.
2015-07-10 Chinese
2015年第一次临时股东大会的法律意见
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the legality and procedures of a company's 2015 first extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. It does not contain financial statements or results but rather certifies the legality and validity of the meeting and its resolutions. The document is not an announcement of voting results per se, but a legal opinion on the meeting's conduct. Given the nature of the document as a legal opinion on a shareholders' meeting, it fits best under Legal Proceedings Report (LTR), which covers updates on significant legal matters involving the company. The document length is under 5,000 characters, but it is not a brief announcement or notice; it is a formal legal opinion. Therefore, the classification is LTR with high confidence.
2015-07-10 Chinese
关于筹划员工持股计划的停牌公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the suspension of trading (停牌公告) due to the company's plan to initiate an employee stock ownership plan. It is a regulatory announcement about a trading halt to ensure fair disclosure and prevent stock price volatility. The document does not contain financial statements, detailed financial data, or a report itself. It is not a report publication announcement since it does not mention any report release. The content fits best under a general regulatory announcement category.
2015-07-08 Chinese
2015年第一临时股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as materials for the "2015 First Extraordinary General Meeting" of 普莱柯生物工程股份有限公司. It contains detailed meeting instructions, agenda, voting procedures, and specific proposals to be discussed and voted on during the meeting. There are no financial statements or financial performance data included. The content is focused on the organization and conduct of the shareholders' meeting, including voting methods and agenda items such as amendments to the company charter and cash management proposals. This matches the description of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting. The document length is 3338 characters, which is consistent with meeting materials rather than a full report or announcement. Therefore, the correct classification is AGM Information (AGM-R).
2015-07-06 Chinese
关于获得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the approval and issuance of a new veterinary drug registration certificate by the Ministry of Agriculture in China. It details the new vaccine product, its significance, and the company's innovation efforts. There is no financial data, no mention of annual or quarterly reports, no voting results, no management changes, no legal proceedings, or other regulatory filings typical of financial or corporate governance reports. The document is an official announcement about a regulatory approval related to product registration, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about a new product certificate. Given the available categories, the best fit is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories. The document length is short and it is not a report publication announcement or certification letter, so RNS is appropriate with high confidence.
2015-07-02 Chinese
公司章程（2015修订）
Governance Information Classification · 100% confidence The document is titled "普莱柯生物工程股份有限公司 公司章程" which translates to "Articles of Association of Pulike Biological Engineering Co., Ltd." It contains detailed chapters about the company's general provisions, business scope, shares issuance and transfer, shareholders and shareholders' meetings, board of directors, senior management, supervisory board, financial accounting system, profit distribution, auditing, notices and announcements, mergers, capital changes, dissolution, and amendments to the articles. The content is a comprehensive governance document outlining the company's internal rules, board structure, shareholder rights, and management responsibilities. There is no indication that this is an annual report, audit report, earnings release, or any other financial or regulatory filing. Instead, it fits the definition of a Governance Information report, which details the company's internal rules and governance practices. The document length is substantial (15,000 characters), indicating it is the full text of the articles, not just an announcement or summary.
2015-06-24 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.